PLUS THERAPEUTICS, INC. — Director's Dealing 2014

May 20, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2014-05-19

Reporting Person: HOLMES E CARMACK (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-05-19	Restricted Stock Award (Common Stock)	A	2867	—	Acquired	13417	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6100	Direct
Common Stock	37401	Indirect

Footnotes

F1: This Restricted Stock Award ("Award") was granted to the board members in lieu of 25% of future estimated cash compensation for their services in the second, third and fourth quarters of 2014. The Award vests in full on January 2, 2015, unless Mr. Holmes voluntarily resigns prior to 1/2/2015, or if he is nominated, but declines to stand for re-election at the Company's 2014 Annual Meeting. Vesting of the Award will be accelerated upon Mr. Holmes' death or failure to be re-elected at the Company's 2014 Annual Meeting.

F2: These shares are held of record by E. Carmack Holmes & Carolyn K Holmes TTEE, Holmes Living Trust DD 05/15/92.